"10.1371_journal.pone.0083280","plos one","2013-12-16T00:00:00Z","Kohei Tatsumi; Mitsuhiko Sugimoto; David Lillicrap; Midori Shima; Kazuo Ohashi; Teruo Okano; Hideto Matsui","Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan; Department of Regulatory Medicine for Thrombosis, Nara Medical University, Kashihara, Nara, Japan; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan","Conceived and designed the experiments: KT M. Sugimoto M. Shima KO TO HM. Performed the experiments: KT HM. Analyzed the data: KT HM. Contributed reagents/materials/analysis tools: KT DL HM. Wrote the paper: KT HM. Provided the constructs for lentiviral vectors used in this study: DL. Provided insights on experimental design: M. Sugimoto M. Shima KO TO. Edited the manuscript: DL M. Sugimoto M. Shima KO TO. Directed and performed the experiments: HM. Conducted data analysis and interpretation: HM.","The Bayer Hemophilia Awards Program partially funded this study. Dr. Teruo Okano is an investor/stockholder in CellSeed, Inc. (Japan) and an inventor/developer designated on the patent for the temperature-responsive culture surfaces (patent nos. JP1972502, US5284766, FR0382214, NL0382214, DE0382214, GB0382214, SE0382214, and CH0382214 respectively). Other authors declare no competing financial interests. There are no further patents, products in development or marked products to declare. This does not alter the authors' adherence to all the PLOS ONE polices on sharing data and materials.","2013","12","Kohei Tatsumi","KT",7,TRUE,2,2,2,2,TRUE,TRUE,TRUE,2,"5;6",TRUE
